SOFIA (Bulgaria), January 19 (SeeNews) – Bulgarian real estate investment trust Sopharma Properties [BUL:6S6] has increased its capital to more than 16.9 million levs ($10 million/8.6 million euro) from 15.7 million levs, data from the country's Central Depository indicated on Monday.
Following the capital increase, the company's capital consists of 16,938,725 shares with a par value of 1 lev each, the Central Depository said in its weekly bulletin.
The purpose of the capital hike was not disclosed.
Sopharma Properties said in September its board decided to increase the company's capital by 7.9% to 16.94 million levs. A month later it received permission for the move from the financial regulator.
The company said at the time that existing shareholders will have the right to subscribe for one share for each 12.79 shares they own.
In July Sopharma Properties abandoned plans to raise its capital after the financial regulator refused to approve its investment prospectus for an identical number of shares with an issue price of 2.85 levs.
Sopharma Properties is majority owned by local blue-chip drug maker Sopharma [BUL:3JR].
Sopharma Properties closed 0.75% higher at 5.4 levs in a volume of 1,573 shares on the Sofia stock exchange on Friday.
(1 euro = 1.95583 Bulgarian levs)